The Federal Service for the Oversight of Consumer Protection and Welfare in Russia has recently taken on a hands-on approach toward the urgent need of addressing the problem against antibiotic-resistant bacteria with bacteriophages.
Proteon Pharmaceuticals receives funding from Nutreco, Aqua-Spark & PFR Life Science for commercializing bacteriophage-based products for livestock and aquaculture.
EU and FAO award Biochimpharm with grant for the production of a new product for veterinary use, PowerPhage.
The National Institute of Allergy and Infectious Diseases (NIAID), has awarded 12 institutes with grants towards phage therapy research.
Phico Therapeutics receives funding from CARB-X towards the development of engineered bacteriophage with SASP gene targeting Pseudomonas aeruginosa.
Synthetic bacteriophages with shortened genome created successfully by scientists from CEB – Centre of Biological Engineering, Braga in Portugal.